ARTICLE | Clinical News
FDA warns of symptom worsening after stopping Gilenya treatment
November 30, 2018 6:25 PM UTC
FDA added a warning to the label of multiple sclerosis drug Gilenya fingolimod from Novartis AG (NYSE:NVS; SIX:NOVN) saying that patients who stop treatment could experience worsening of symptoms...
BCIQ Company Profiles
BCIQ Target Profiles